Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05008588
PHASE1/PHASE2

Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

Sponsor: PT. Prodia Stem Cell Indonesia

View on ClinicalTrials.gov

Summary

The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in acute stroke patients to induce neurogenesis.

Official title: Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct

Key Details

Gender

All

Age Range

25 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2022-05-30

Completion Date

2026-03

Last Updated

2026-02-25

Healthy Volunteers

No

Conditions

Interventions

BIOLOGICAL

Conditioned Medium

Intranasal of 3 cc of conditioned medium each, for 3 days in a row

BIOLOGICAL

Umbilical Cord Mesenchymal Stem Cells

Intra-parenchymal transplantation of 20x10\^6 UC-MSCs

PROCEDURE

Neurologic and Neutrophic Drugs

Such as clopidogrel, piracetam, citicoline

Locations (2)

Gatot Soebroto Hospital

Jakarta Pusat, DKI Jakarta, Indonesia

PT Prodia StemCell Indonesia

Jakarta, Indonesia